Merrimack Pharmaceuticals, Inc

Closed
Call
Website
1 Broadway Ste 14
Cambridge, MA 02142
+1 (617) 720-8606
https://www.merrimack.com
Merrimack Pharmaceuticals is a privately held integrated biotechnology company. The company is dedicated to the discovery and development of therapies for the treatment of autoimmune disease and cancer. Its goal is to provide patients and physicians with some of the best possible treatments and support its pharmaceuticals with the tools to enable the prescription of the right drug for the right patient. The company is advancing a pipeline of clinical and early-stage biologics that represent patient-directed, targeted therapies. Its discovery and development efforts are founded on its proprietary Network Biology research engine. Its lead product, MM-093, is in clinical trials for the treatment of patients with rheumatoid arthritis and psoriasis. Merrimack Pharmaceuticals is based in Cambridge, Mass.

Also at this address

Own this business?
See a problem?

You might also like

Merck Research Laboratories
Psychiatrists and psychoanalysts, Business services, nec, nec

Merck Research Laboratories

Merck Research Laboratories, based in Boston, MA, has been at the forefront of biopharmaceutical innovation for over 130 years, focusing on the development of significant medicines and vaccines aimed at improving global health. Their research encompasses various areas, including oncology, infectious diseases, and immunology, while actively pursuing innovative scientific advancements through collaborations and clinical trials. The company is dedicated to operating sustainably and responsibly, ensuring a safe and healthy future for communities worldwide. Through initiatives like the Merck for Mothers program and the Patient Assistance Program, Merck demonstrates its commitment to making healthcare accessible and impactful for all individuals. Generated from the website
Momenta Pharmaceuticals
Real estate managers, Business services, nec, nec, Drugs and drug proprietaries

Momenta Pharmaceuticals

Alnylam Pharmaceuticals is a biopharmaceutical company. The company develops novel therapeutics based on the biological breakthrough known as ribonucleic acid interference. The company applies ribonucleic acid interference to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies. This discovery enables the creation of a broad new class of human therapeutics. Alnylam Pharmaceuticals maintains partnerships with leading pharmaceutical and medical technology companies to drive further developments and capabilities. Major alliances include Merck, Medtronic and Novartis. Alnylam Pharmaceuticals, founded in 2002, maintains global headquarters in Cambridge, Mass., and has an additional operating unit in Kulmbach, Germany.
Business services, nec, nec, Feathers and feather products

Takeda Pharmaceuticals

Takeda Pharmaceuticals USA, based in Cambridge, MA, is a global pharmaceutical company dedicated to creating better health for people and a brighter future for the world. With a focus on research and development, Takeda strives to transform lives through innovative medicines in areas such as gastrointestinal and inflammation, rare diseases, oncology, neuroscience, plasma-derived therapies, and vaccines. Committed to sustainability and corporate responsibility, Takeda emphasizes access to medicines, ethical practices, and transparency in governance. Through collaboration with diverse colleagues and a patient-centered approach, Takeda continues to advance science and technology to improve healthcare outcomes worldwide. Generated from the website
United States›Massachusetts›Cambridge›Merrimack Pharmaceuticals, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.